Skip to main content
ConductScienceScienceDex

ScienceDex / Researcher record

Windisch, Manfred

From the FY2019 NIH awards this investigator leads as contact PI. The department is the award's.

FY2019 NIH rank #1,787
Unclaimed recordClaim profile
  • R01 Holder
  • Top 10% Funded
  • Early Career

NIH Funding · FY2019

Linked Award Amount
$2.8M
Full award amounts, FY2019
Award Records
2
Records listing this PI
Award-Linked Rank
#1,787
By linked amount among FY2019 PIs
Earliest Year Loaded
2016
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2016$1,499,8741#4,064
2017$1,499,5441#4,045
2018$1,495,4471#4,360
2019$2,804,1832#1,787

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20161 record
  2. FY20171 record
  3. FY20181 record
  4. FY2019 · selected2 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Windisch, Manfred. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2019 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2016 through FY2019Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2019 award records by amount

NIH award records listing Windisch, Manfred as a PI. Multi-PI records show the full award amount for context.

  • 3R01AG051596-03S2R01Contact PI
    A double-blinded, randomized, controlled phase 2a safety, proof-of-concept and exploratory end point trial of the drug LM11A-31 in patients with mild to moderate Alzheimer's disease.
    Pharmatrophix, Inc.
    $2.6M
    award amount
  • 3R01AG051596-03S1R01Contact PI
    A double-blinded, randomized, controlled phase 2a safety, proof-of-concept and exploratory end point trial of the drug LM11A-31 in patients with mild to moderate Alzheimer's disease.
    Pharmatrophix, Inc.
    $245K
    award amount

Award organization

Organizations that administered FY2019 awards listing Windisch, Manfred as a PI.

FY2019 award administered by Pharmatrophix, Inc. ().

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2016
    First NIH Award
    Pharmatrophix, Inc.
  2. 2016
    $500K Cumulative Funding
  3. 2016
    $1M Cumulative Funding
  4. 2016
    Entered Top 50% Nationally
    Ranked #4064
  5. 2016
    Entered Top 25% Nationally
    Ranked #4064
  6. 2017
    $2M Cumulative Funding
  7. 2017
    R01 Grant Holder
  8. 2019
    $5M Cumulative Funding
  9. 2019
    Entered Top 10% Nationally
    Ranked #1787

Explore further

Find collaborators for Windisch, Manfred

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →